Supply, implementation and support of PCR-based CFTR variant testing assays
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Apr 21,Expired
- Award
- Technical Spec, Clinical Relevance and Support
Brief
Children's Health Ireland (CHI) has entered into an agreement with Youregene Heath UK Ltd for the supply, implementation, and support of PCR-based CFTR variant testing assays. The assays are intended for genetic testing related to Cystic Fibrosis (CF) and CF-related disorders, including diagnostic confirmation, carrier screening, and newborn screening follow-up. The contract has a duration of 60 months and a final value of 400,000 EUR.
Engroshandel med medisinske og husholdningsvarer
Result
- Yourgene Health UK LtdWinner
- 1Number of tenders received
- €400,000Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Children's Health Ireland (CHI)
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Cost
Source
No source found in the documents. Check the weight against the tender documents.
Description
Technical Spec, Clinical Relevance and Support
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
We are seeking an assay for Cystic fibrosis (CF) and cystic fibrosis related disorders caused by pathogenic variants in the CFTR gene. The intended use of this assay is Genetic testing for: • Diagnostic confirmation • Carrier screening • Newborn screening (NBS) follow-up after elevated immunoreactive trypsinogen (IRT) results.
Contact
robert.keogh@olhsc.ie- ResultType
- DublinLocation
- 33140000Main codeMedical consumables
- 33124130Diagnostic supplies33694000Diagnostic agents33696500Laboratory reagents